12/31false00014982332023Q30.1257P1YP3YP3Y00014982332023-01-012023-09-300001498233us-gaap:CommonStockMember2023-01-012023-09-300001498233us-gaap:WarrantMember2023-01-012023-09-3000014982332023-11-01xbrli:shares00014982332023-09-30iso4217:USDxbrli:sharesiso4217:USD00014982332022-12-310001498233us-gaap:ProductMember2023-07-012023-09-300001498233us-gaap:ProductMember2022-07-012022-09-300001498233us-gaap:ProductMember2023-01-012023-09-300001498233us-gaap:ProductMember2022-01-012022-09-300001498233gcac:DevelopmentRevenueMember2023-07-012023-09-300001498233gcac:DevelopmentRevenueMember2022-07-012022-09-300001498233gcac:DevelopmentRevenueMember2023-01-012023-09-300001498233gcac:DevelopmentRevenueMember2022-01-012022-09-3000014982332023-07-012023-09-3000014982332022-07-012022-09-3000014982332022-01-012022-09-300001498233us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-12-310001498233us-gaap:AdditionalPaidInCapitalMember2022-12-310001498233us-gaap:AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMember2022-12-310001498233us-gaap:RetainedEarningsMember2022-12-3100014982332023-01-012023-03-310001498233us-gaap:CommonStockMemberus-gaap:CommonClassAMember2023-01-012023-03-310001498233us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001498233us-gaap:AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMember2023-01-012023-03-310001498233us-gaap:RetainedEarningsMember2023-01-012023-03-3100014982332023-03-310001498233us-gaap:CommonStockMemberus-gaap:CommonClassAMember2023-03-310001498233us-gaap:AdditionalPaidInCapitalMember2023-03-310001498233us-gaap:AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMember2023-03-310001498233us-gaap:RetainedEarningsMember2023-03-310001498233us-gaap:CommonStockMemberus-gaap:CommonClassAMember2023-04-012023-06-300001498233us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-3000014982332023-04-012023-06-300001498233us-gaap:AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMember2023-04-012023-06-300001498233us-gaap:RetainedEarningsMember2023-04-012023-06-3000014982332023-06-300001498233us-gaap:CommonStockMemberus-gaap:CommonClassAMember2023-06-300001498233us-gaap:AdditionalPaidInCapitalMember2023-06-300001498233us-gaap:AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMember2023-06-300001498233us-gaap:RetainedEarningsMember2023-06-300001498233us-gaap:CommonStockMemberus-gaap:CommonClassAMember2023-07-012023-09-300001498233us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300001498233us-gaap:AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMember2023-07-012023-09-300001498233us-gaap:RetainedEarningsMember2023-07-012023-09-300001498233us-gaap:CommonStockMemberus-gaap:CommonClassAMember2023-09-300001498233us-gaap:AdditionalPaidInCapitalMember2023-09-300001498233us-gaap:AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMember2023-09-300001498233us-gaap:RetainedEarningsMember2023-09-3000014982332021-12-310001498233us-gaap:PreferredStockMember2021-12-310001498233us-gaap:CommonStockMemberus-gaap:CommonClassAMember2021-12-310001498233us-gaap:CommonStockMembergcac:CommonClassFMember2021-12-310001498233us-gaap:AdditionalPaidInCapitalMember2021-12-310001498233us-gaap:AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMember2021-12-310001498233us-gaap:RetainedEarningsMember2021-12-3100014982332022-01-012022-03-310001498233us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-01-012022-03-310001498233us-gaap:CommonStockMembergcac:CommonClassFMember2022-01-012022-03-310001498233us-gaap:AdditionalPaidInCapitalMember2022-01-012022-03-310001498233us-gaap:RetainedEarningsMember2022-01-012022-03-310001498233us-gaap:CommonStockMemberus-gaap:CommonClassAMembergcac:TrinityWarrantsMember2022-01-012022-03-310001498233us-gaap:AdditionalPaidInCapitalMembergcac:TrinityWarrantsMember2022-01-012022-03-310001498233gcac:TrinityWarrantsMember2022-01-012022-03-310001498233us-gaap:CommonStockMembergcac:SVBWarrantsMemberus-gaap:CommonClassAMember2022-01-012022-03-310001498233us-gaap:AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMember2022-01-012022-03-3100014982332022-03-310001498233us-gaap:PreferredStockMember2022-03-310001498233us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-03-310001498233us-gaap:CommonStockMembergcac:CommonClassFMember2022-03-310001498233us-gaap:AdditionalPaidInCapitalMember2022-03-310001498233us-gaap:AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMember2022-03-310001498233us-gaap:RetainedEarningsMember2022-03-310001498233us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-04-012022-06-300001498233us-gaap:AdditionalPaidInCapitalMember2022-04-012022-06-3000014982332022-04-012022-06-300001498233us-gaap:AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMember2022-04-012022-06-300001498233us-gaap:RetainedEarningsMember2022-04-012022-06-3000014982332022-06-300001498233us-gaap:PreferredStockMember2022-06-300001498233us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-06-300001498233us-gaap:CommonStockMembergcac:CommonClassFMember2022-06-300001498233us-gaap:AdditionalPaidInCapitalMember2022-06-300001498233us-gaap:AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMember2022-06-300001498233us-gaap:RetainedEarningsMember2022-06-300001498233us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-07-012022-09-300001498233us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300001498233us-gaap:AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMember2022-07-012022-09-300001498233us-gaap:RetainedEarningsMember2022-07-012022-09-3000014982332022-09-300001498233us-gaap:PreferredStockMember2022-09-300001498233us-gaap:CommonStockMemberus-gaap:CommonClassAMember2022-09-300001498233us-gaap:CommonStockMembergcac:CommonClassFMember2022-09-300001498233us-gaap:AdditionalPaidInCapitalMember2022-09-300001498233us-gaap:AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMember2022-09-300001498233us-gaap:RetainedEarningsMember2022-09-300001498233us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMembergcac:ThreeCustomersMember2023-07-012023-09-30xbrli:pure0001498233us-gaap:CustomerConcentrationRiskMemberus-gaap:AccountsReceivableMembergcac:TwoCustomersMember2023-01-012023-06-300001498233us-gaap:CustomerConcentrationRiskMembergcac:CustomerAMemberus-gaap:SalesRevenueNetMember2023-07-012023-09-300001498233us-gaap:CustomerConcentrationRiskMembergcac:CustomerAMemberus-gaap:SalesRevenueNetMember2022-07-012022-09-300001498233us-gaap:CustomerConcentrationRiskMembergcac:CustomerAMemberus-gaap:SalesRevenueNetMember2023-01-012023-09-300001498233us-gaap:CustomerConcentrationRiskMembergcac:CustomerAMemberus-gaap:SalesRevenueNetMember2022-01-012022-09-300001498233us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembergcac:CustomerBMember2023-07-012023-09-300001498233us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembergcac:CustomerBMember2022-07-012022-09-300001498233us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembergcac:CustomerBMember2023-01-012023-09-300001498233us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembergcac:CustomerBMember2022-01-012022-09-300001498233us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembergcac:CustomerCMember2023-07-012023-09-300001498233us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembergcac:CustomerCMember2022-07-012022-09-300001498233us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembergcac:CustomerCMember2023-01-012023-09-300001498233us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembergcac:CustomerCMember2022-01-012022-09-300001498233us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembergcac:CustomerDMember2023-07-012023-09-300001498233us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembergcac:CustomerDMember2022-07-012022-09-300001498233us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembergcac:CustomerDMember2023-01-012023-09-300001498233us-gaap:CustomerConcentrationRiskMemberus-gaap:SalesRevenueNetMembergcac:CustomerDMember2022-01-012022-09-3000014982332023-09-072023-09-0700014982332022-02-102023-09-3000014982332022-02-100001498233country:JP2023-07-012023-09-300001498233country:JP2022-07-012022-09-300001498233country:US2023-07-012023-09-300001498233country:US2022-07-012022-09-300001498233country:CN2023-07-012023-09-300001498233country:CN2022-07-012022-09-300001498233gcac:OtherMember2023-07-012023-09-300001498233gcac:OtherMember2022-07-012022-09-300001498233country:JP2023-01-012023-09-300001498233country:JP2022-01-012022-09-300001498233country:US2023-01-012023-09-300001498233country:US2022-01-012022-09-300001498233country:CN2023-01-012023-09-300001498233country:CN2022-01-012022-09-300001498233gcac:OtherMember2023-01-012023-09-300001498233gcac:OtherMember2022-01-012022-09-300001498233us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2023-09-300001498233us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Member2023-09-300001498233us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Member2023-09-300001498233us-gaap:MoneyMarketFundsMember2023-09-300001498233us-gaap:FairValueInputsLevel1Member2023-09-300001498233us-gaap:FairValueInputsLevel2Member2023-09-300001498233us-gaap:FairValueInputsLevel3Member2023-09-300001498233us-gaap:FairValueInputsLevel1Memberus-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2023-09-300001498233us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel2Member2023-09-300001498233us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMemberus-gaap:FairValueInputsLevel3Member2023-09-300001498233us-gaap:CommercialPaperNotIncludedWithCashAndCashEquivalentsMember2023-09-300001498233us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2023-09-300001498233us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2023-09-300001498233us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2023-09-300001498233us-gaap:USGovernmentAgenciesDebtSecuritiesMember2023-09-300001498233us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2022-12-310001498233us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel2Member2022-12-310001498233us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel3Member2022-12-310001498233us-gaap:MoneyMarketFundsMember2022-12-310001498233us-gaap:FairValueInputsLevel1Member2022-12-310001498233us-gaap:FairValueInputsLevel2Member2022-12-310001498233us-gaap:FairValueInputsLevel3Member2022-12-310001498233us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2022-12-310001498233us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2022-12-310001498233us-gaap:USGovernmentAgenciesDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2022-12-310001498233us-gaap:USGovernmentAgenciesDebtSecuritiesMember2022-12-310001498233us-gaap:FairValueInputsLevel1Memberus-gaap:CorporateDebtSecuritiesMember2022-12-310001498233us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMember2022-12-310001498233us-gaap:CorporateDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2022-12-310001498233us-gaap:CorporateDebtSecuritiesMember2022-12-310001498233gcac:EarnoutLiabilityMember2022-12-310001498233gcac:EarnoutLiabilityMember2023-01-012023-09-300001498233gcac:EarnoutLiabilityMember2023-09-300001498233us-gaap:MachineryAndEquipmentMember2023-09-300001498233us-gaap:MachineryAndEquipmentMember2022-12-310001498233us-gaap:VehiclesMember2023-09-300001498233us-gaap:VehiclesMember2022-12-310001498233us-gaap:LeaseholdImprovementsMember2023-09-300001498233us-gaap:LeaseholdImprovementsMember2022-12-310001498233us-gaap:ComputerEquipmentMember2023-09-300001498233us-gaap:ComputerEquipmentMember2022-12-310001498233gcac:TrinityLoanAgreementMemberus-gaap:LoansPayableMember2022-01-040001498233us-gaap:LoansPayableMembergcac:TrinityLoanAgreementMember2022-01-040001498233us-gaap:LoansPayableMembergcac:TrinityLoanAgreementMemberus-gaap:PrimeRateMember2022-01-042022-01-0400014982332022-01-042022-01-0400014982332022-01-040001498233gcac:TrinityLoanAgreementMemberus-gaap:LoansPayableMember2022-01-042022-01-040001498233gcac:TrinityLoanAgreementMemberus-gaap:LoansPayableMember2022-11-072022-11-070001498233us-gaap:SecuredDebtMemberus-gaap:RelatedPartyMemberus-gaap:SecuredDebtMember2022-10-27iso4217:JPY0001498233us-gaap:SecuredDebtMemberus-gaap:SecuredDebtMemberus-gaap:RelatedPartyMember2022-10-270001498233us-gaap:SecuredDebtMembergcac:SecuredTermLoanAgreementMember2022-10-272022-10-27gcac:businessDay0001498233us-gaap:SecuredDebtMemberus-gaap:RelatedPartyMember2023-01-012023-09-300001498233us-gaap:RelatedPartyMember2023-01-242023-01-2400014982332023-01-242023-01-2400014982332022-02-090001498233us-gaap:RelatedPartyMemberus-gaap:PrivatePlacementMemberus-gaap:ConvertiblePreferredStockMember2022-10-272022-10-2700014982332022-10-2700014982332023-01-192023-01-190001498233us-gaap:PrivatePlacementMemberus-gaap:ConvertiblePreferredStockMember2023-01-192023-01-1900014982332022-10-272022-10-27gcac:vote0001498233us-gaap:PrivatePlacementMember2021-11-240001498233us-gaap:PrivatePlacementMember2021-11-242021-11-2400014982332021-11-242021-11-24gcac:salesPricegcac:salesPriceDay0001498233us-gaap:PrivatePlacementMemberus-gaap:CommonClassAMember2021-11-242021-11-240001498233us-gaap:PrivatePlacementMemberus-gaap:CommonClassAMember2022-08-092022-08-0900014982332022-08-092022-08-090001498233us-gaap:PrivatePlacementMember2023-01-012023-09-300001498233us-gaap:PrivatePlacementMember2023-09-300001498233us-gaap:PrivatePlacementMemberus-gaap:CommonClassAMember2023-01-012023-09-300001498233us-gaap:PrivatePlacementMemberus-gaap:CommonClassAMember2023-07-012023-09-300001498233us-gaap:PrivatePlacementMember2022-07-012022-09-300001498233us-gaap:PrivatePlacementMember2022-01-012022-09-300001498233gcac:CommonClassFMember2023-01-012023-09-300001498233gcac:A2016PlanMember2016-07-050001498233gcac:A2022StockPlanMember2022-02-100001498233gcac:A2022StockPlanMember2022-02-102023-09-300001498233gcac:A2022StockPlanMember2023-09-300001498233us-gaap:EmployeeStockOptionMember2023-09-300001498233us-gaap:EmployeeStockOptionMember2023-01-012023-09-300001498233gcac:A2022StockPlanMemberus-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001498233srt:MinimumMemberus-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001498233srt:MaximumMemberus-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001498233us-gaap:RestrictedStockUnitsRSUMember2022-12-310001498233us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-300001498233us-gaap:RestrictedStockUnitsRSUMember2023-09-300001498233gcac:A2022StockPlanMemberus-gaap:PerformanceSharesMember2023-01-012023-09-300001498233us-gaap:PerformanceSharesMember2023-01-012023-09-300001498233us-gaap:PerformanceSharesMember2022-01-012022-09-300001498233us-gaap:ShareBasedCompensationAwardTrancheOneMemberus-gaap:PerformanceSharesMember2022-01-012022-09-300001498233us-gaap:ShareBasedCompensationAwardTrancheTwoMemberus-gaap:PerformanceSharesMember2022-01-012022-09-30gcac:tranche0001498233us-gaap:ShareBasedCompensationAwardTrancheOneMemberus-gaap:PerformanceSharesMember2023-01-012023-09-30gcac:tradingDay0001498233us-gaap:ShareBasedCompensationAwardTrancheOneMemberus-gaap:PerformanceSharesMember2023-09-300001498233us-gaap:ShareBasedCompensationAwardTrancheTwoMemberus-gaap:PerformanceSharesMember2023-01-012023-09-300001498233us-gaap:ShareBasedCompensationAwardTrancheTwoMemberus-gaap:PerformanceSharesMember2023-09-300001498233us-gaap:CostOfSalesMember2023-07-012023-09-300001498233us-gaap:CostOfSalesMember2022-07-012022-09-300001498233us-gaap:CostOfSalesMember2023-01-012023-09-300001498233us-gaap:CostOfSalesMember2022-01-012022-09-300001498233us-gaap:ResearchAndDevelopmentExpenseMember2023-07-012023-09-300001498233us-gaap:ResearchAndDevelopmentExpenseMember2022-07-012022-09-300001498233us-gaap:ResearchAndDevelopmentExpenseMember2023-01-012023-09-300001498233us-gaap:ResearchAndDevelopmentExpenseMember2022-01-012022-09-300001498233us-gaap:GeneralAndAdministrativeExpenseMember2023-07-012023-09-300001498233us-gaap:GeneralAndAdministrativeExpenseMember2022-07-012022-09-300001498233us-gaap:GeneralAndAdministrativeExpenseMember2023-01-012023-09-300001498233us-gaap:GeneralAndAdministrativeExpenseMember2022-01-012022-09-300001498233us-gaap:CommonClassAMemberus-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMembergcac:SharePriceOneMember2023-09-300001498233us-gaap:CommonClassAMemberus-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMembergcac:SharePriceOneMember2023-01-012023-09-300001498233us-gaap:CommonClassAMembergcac:SharePriceTwoMemberus-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember2023-09-300001498233us-gaap:CommonClassAMembergcac:SharePriceTwoMember2023-01-012023-09-300001498233us-gaap:CommonClassAMembergcac:SharePriceTwoMember2023-09-3000014982332022-02-102022-12-300001498233us-gaap:IPOMember2023-09-300001498233us-gaap:IPOMemberus-gaap:CommonClassAMember2023-09-300001498233us-gaap:CommonClassAMember2023-09-300001498233us-gaap:PrivatePlacementMembergcac:SponsorMember2023-07-012023-09-300001498233gcac:BusinessCombinationMember2023-09-300001498233us-gaap:SecuredDebtMemberus-gaap:LineOfCreditMembergcac:A2019LoanAgreementMember2019-08-3100014982332019-08-310001498233us-gaap:RelatedPartyMembergcac:AssignmentToBoardOfDirectorsMember2023-01-192023-01-19gcac:designee0001498233us-gaap:RelatedPartyMember2023-09-300001498233us-gaap:RelatedPartyMember2022-12-310001498233us-gaap:EmployeeStockOptionMember2023-07-012023-09-300001498233us-gaap:EmployeeStockOptionMember2022-07-012022-09-300001498233us-gaap:EmployeeStockOptionMember2023-01-012023-09-300001498233us-gaap:EmployeeStockOptionMember2022-01-012022-09-300001498233gcac:PreferredSharesOnAnAsConvertedBasisMember2023-07-012023-09-300001498233gcac:PreferredSharesOnAnAsConvertedBasisMember2022-07-012022-09-300001498233gcac:PreferredSharesOnAnAsConvertedBasisMember2023-01-012023-09-300001498233gcac:PreferredSharesOnAnAsConvertedBasisMember2022-01-012022-09-300001498233gcac:EarnoutSharesMember2023-01-012023-09-300001498233us-gaap:ConvertiblePreferredStockMember2022-01-012022-09-300001498233us-gaap:ConvertiblePreferredStockMember2023-01-012023-09-300001498233us-gaap:ConvertiblePreferredStockMember2023-09-30gcac:segment

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o No x

As of November 1, 2023, 15,846,935 shares of common stock, par value $0.00001, of the registrant were issued and outstanding.

This Quarterly Report on Form 10-Q (the “Report”) includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements other than statements of historical or current fact included in this Report are forward-looking statements. Forward-looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “will,” “expect,” “anticipate,” “believe,” “seek,” “target,” “designed to” or other similar expressions that predict or imply future events or trends or that are not statements of historical matters. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The Company cautions readers of this Report that these forward-looking statements are subject to risks and uncertainties, most of which are difficult to predict and many of which are beyond the Company’s control, that could cause the actual results to differ materially from the expected results. These factors include the information set forth in Part II, Item 1A, of this Report under the heading “Risk Factors”, which we encourage you to carefully read. Forward-looking statements include, but are not limited to, statements regarding estimates and forecasts of financial and performance metrics, projections of market opportunity and market share, the anticipated start date of production for our lead series production award, potential benefits and the commercial attractiveness to its customers of the Company’s products and services, the potential success of the Company’s marketing and expansion strategies, and the potential for the Company to achieve design awards. These statements are based on various assumptions, whether or not identified in this Report, and on the current expectations of the Company’s management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on by any investor as, a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. You are therefore cautioned not to place undue reliance on such statements. Any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events, except as required by law.

(In thousands, except share data)

(unaudited)

(unaudited)

(unaudited)

(In thousands)

(unaudited)

			Nine Months Ended September 30,
			2023						2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net (loss) income			$	(40,226)					$	24,631
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation and amortization			370						224
Stock-based compensation			6,989						5,954
Amortization of right-of-use asset			1,177						993
Amortization (accretion), other			(682)						838
Gain on change in fair value of earnout liability			(827)						(70,868)
Gain on change in fair value of warrant liability			(299)						(2,549)
Foreign currency transaction loss, net			757						—
Loss from extinguishment of debt			1,123						—
Other			—						181
Changes in operating assets and liabilities:
Accounts receivable, net			(802)						(886)
Inventories			(941)						7
Prepaid expenses and other current assets			2,974						(472)
Other long-term assets			202						(864)
Accounts payable			(805)						(807)
Accrued expenses and other current liabilities			1,144						962
Operating lease liabilities			(680)						(1,169)
Other long-term liabilities			—						320
Net cash used in operating activities			(30,526)						(43,505)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property and equipment			(1,292)						(584)
Purchases of short-term investments			(37,806)						(32,368)
Proceeds from sales of short-term investments			—						8,303
Proceeds from maturities of short-term investments			25,200						8,624
Net cash used in investing activities			(13,898)						(16,025)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from convertible preferred stock, net of transaction costs			99,884						—
Repayment of Koito secured term loan			(45,220)						—
Proceeds from Business Combination and private offering			—						76,107
Payments of Business Combination and private offering transaction costs			—						(29,031)
Proceeds from issuance of debt and warrants, net of debt discount			—						9,724
Proceeds from issuance of common stock options			22						707
Payments of employee taxes related to vested restricted stock units			(63)						—
Issuance of common stock			—						1,700
Net cash provided by financing activities			54,623						59,207
Effect of exchange rate changes on cash			426						(19)
Net increase (decrease) in cash, cash equivalents and restricted cash			10,625						(342)
Cash, cash equivalents and restricted cash, beginning of period			34,518						3,654
Cash, cash equivalents and restricted cash, end of period			$	45,143					$	3,312

Notes to Condensed Consolidated Financial Statements (Unaudited) (

Cepton, Inc., and its wholly owned subsidiaries, (collectively, the “Company”) formerly known as Growth Capital Acquisition Corp. (“GCAC”), was originally incorporated in Delaware on January 4, 2010, under the name PinstripesNYS, Inc. GCAC changed its name to Growth Capital Acquisition Corp. on February 14, 2020. GCAC was a special purpose acquisition company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more target businesses. On February 2, 2021, the Company consummated its initial public offering (the “IPO”), following which its shares began trading on the Nasdaq Stock Market (“Nasdaq”). On August 4, 2021, GCAC entered into a Business Combination Agreement (as amended, the “Merger Agreement”) with Cepton Technologies, Inc. (“Legacy Cepton”) and GCAC Merger Sub Inc., a wholly owned subsidiary of GCAC (“Merger Sub”). On February 10, 2022 (the “Closing Date”), the transactions contemplated by the Merger Agreement (the “Business Combination”) were consummated. In connection with the closing of the Business Combination, GCAC changed its name to Cepton, Inc. and its shares and public warrants began trading on Nasdaq under the symbols “CPTN” and “CPTNW”, respectively. As a result of the Business Combination, Cepton, Inc. became the owner, directly or indirectly, of all of the equity interests of Legacy Cepton and its subsidiaries.

The Company provides state-of-the-art, intelligent, lidar-based solutions for a range of markets such as automotive, smart cities, smart spaces, and smart industrial applications. The Company’s patented lidar technology enables reliable, scalable, and cost-effective solutions that deliver long range, high resolution 3D perception for smart applications. The Company is headquartered in San Jose, California, USA, with a presence in Germany, Canada, China and India.

The condensed consolidated financial statements are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The condensed consolidated financial statements include the accounts of the Company’s wholly owned subsidiaries in Canada, Germany, China and the United Kingdom. All intercompany balances and transactions have been eliminated in consolidation. The condensed consolidated financial statements include all adjustments considered necessary by management to fairly state the results of operations, financial position and cash flows. The accompanying interim unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and related notes thereto for the year ended December 31, 2022 included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.

The accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. As of September 30, 2023, the Company had cash and cash equivalents of $43.9 million, short-term investments of $17.3 million, and an accumulated deficit of $126.3 million. During the nine months ended September 30, 2023, the Company incurred an operating loss of $41.5 million and had negative cash flows from operating activities of $30.5 million. The Company believes that its cash position, including cash available from the Purchase Agreement with Lincoln Park (each as defined below in Note 11), will be sufficient to satisfy foreseeable liquidity needs and capital expenditure requirements, including for at least the next twelve months.

The Company is subject to risks and uncertainties frequently encountered by early-stage companies including, but not limited to, the uncertainty of successfully developing its products, securing certain contracts, building its customer base, successfully executing its business and marketing strategy and hiring appropriate personnel.

To date, the Company has been funded primarily by equity financings, convertible promissory notes, and the net proceeds received through the Business Combination, PIPE Investment (as defined below in Note 2), and private placements of the Legacy Cepton convertible preferred stock. Failure to generate sufficient revenues, achieve planned gross margins and operating profitability, control operating costs, or secure additional funding may require the Company to modify, delay, or abandon some of its planned future expansion or development, or to otherwise enact operating cost reductions available to management, which could have a material adverse effect on the Company’s business, operating results, financial condition, and ability to achieve its intended business objectives.

On September 7, 2023, the Company’s stockholders approved a one-for-ten reverse stock split of the Company’s issued common stock (the “Reverse Stock Split”) and a corresponding reduction in the total number of shares of common stock the Company is authorized to issue (the “Authorized Shares Reduction”). On September 18, 2023, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment to its Second Amended and Restated Certificate of Incorporation to effect the Reverse Stock Split and Authorized Shares Reduction.

The Reverse Stock Split and Authorized Shares Reduction became effective on September 21, 2023 (“Effective Date”). The par value of the Company’s common stock was not adjusted as a result of the Reverse Stock Split. All of the Company’s share numbers, per share amounts, and related stockholders’ equity (deficit) balances presented herein have been retroactively adjusted to reflect the Reverse Stock Split. In addition, the exercise prices, conversion rates and other terms of the Company’s securities that adjusted pursuant to their terms as a result of the Reverse Stock Split have been presented after giving effect to such adjustments.

Financial instruments that subject the Company to concentrations of credit risk consist primarily of cash and cash equivalents, short-term investments, and accounts receivable. The Company maintains a substantial portion of its cash and cash equivalents and short-term investments in money market funds, commercial paper, corporate debt securities, and U.S. government agency securities. Management believes that the financial institutions that hold its cash, cash equivalents, and short-term investments are financially sound and, accordingly, represent minimal credit risk. Deposits held with banks may exceed the amount of federal insurance limits provided on such deposits.

As of September 30, 2023 and December 31, 2022, two and two customers, respectively, each accounted for more than 10% of accounts receivable.

Customers with revenue equal to or greater than 10% of total revenue for the periods indicated were as follows:

The preparation of the condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant items subject to such estimates and assumptions include, but are not limited to, inventory valuation and reserves, warranty reserves, valuation allowance for deferred tax assets, valuation of earnout and warrant liabilities, stock-based compensation, useful lives of property and equipment, income tax uncertainties, and other loss contingencies. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could differ from those estimates, and such differences could be material to the Company’s condensed consolidated financial condition and results of operations.

The Company typically provides a one-year warranty on its products. Estimated future warranty costs are accrued and charged to cost of goods sold in the period that the related revenue is recognized. These estimates are derived from historical data and trends of product reliability and costs of repairing and replacing defective products. The Company periodically assesses the adequacy of its recorded warranty liabilities and adjusts the amounts as necessary. Through September 30, 2023, there were immaterial changes to the accrued warranty liability which was recorded in accrued expenses and other current liabilities on the condensed consolidated balance sheet.

Certain reclassifications have been made to prior-period amounts to conform to current-period reporting classifications.

In June 2016, the Financial Standards Accounting Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which significantly changes the way entities recognize credit losses and impairment of financial assets recorded at amortized cost. Currently, the credit loss and impairment model for loans and leases is based on incurred losses, and investments are recognized as impaired when there is no longer an assumption that future cash flows will be collected in full under the originally contracted terms. Under the new current expected credit loss (“CECL”) model, the standard requires immediate recognition of estimated credit losses expected to occur over the remaining life of the asset. The Company adopted this standard on January 1, 2023 utilizing the modified retrospective method, and the adoption did not have a material impact on its condensed consolidated financial statements.

In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40)—Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, which simplifies the accounting for convertible instruments by reducing the number of accounting models available for convertible debt instruments and convertible preferred stock. This update also amends the guidance for the derivatives scope exception for contracts in an entity’s own equity to reduce form-over-substance-based accounting conclusions. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. The update also requires entities to provide expanded disclosures about the terms and features of convertible instruments, how the instruments have been reported in the entity’s financial statements, and information about events, conditions, and circumstances that can affect how to assess the amount or timing of an entity’s future cash flows related to those instruments. The guidance is effective for interim and annual periods beginning after December 15, 2023 for smaller reporting companies. The Company is currently evaluating the potential impact on its condensed consolidated financial statements and related disclosures from the adoption of this standard.

On February 10, 2022, the Business Combination was consummated and the following disclosure has been retained from our previously filed Form 10-K for the comparative prior period in 2022.

The Business Combination was accounted for as a reverse recapitalization as Legacy Cepton was determined to be the accounting acquirer under FASB ASC Topic 805, Business Combinations (ASC 805).

In connection with the Business Combination, outstanding capital stock of Legacy Cepton was converted into common stock of Legacy Cepton and then subsequently converted into Class A common stock of the Company, representing a recapitalization, and the net assets of the Company were acquired at historical cost, with no goodwill or intangible assets recorded. Legacy Cepton was deemed to be the predecessor of the Company, and the consolidated assets and liabilities and results of operations prior to the Closing Date are those of Legacy Cepton. The shares and corresponding capital amounts prior to the Business Combination, have been retroactively restated as shares reflecting an exchange ratio of approximately 2.449 (the “Exchange Ratio”). Operations prior to the Business Combination were those of Legacy Cepton in future reports of the combined entity.

Contemporaneously with the execution of the Merger Agreement, GCAC entered into subscription agreements with certain investors (the “PIPE Investors”), pursuant to which the PIPE Investors agreed to purchase an aggregate of 595,000 shares of common stock at a purchase price of $100.00 per share (as adjusted to reflect the Reverse Stock Split), or an aggregate purchase price of $59.5 million (the “PIPE Investment”).

GCAC warrants issued in connection with the IPO (“Public Warrants”) and in connection with the private placement units held by the Sponsor (“Private Placement Warrants”) remained outstanding after the closing of the Business Combination. The Public Warrants are equity-classified and were valued based on the instruments’ publicly listed trading price as of the Closing Date. The Private Placement Warrants are liability-classified and are valued on a recurring basis with changes in fair value recognized as a gain or loss upon remeasurement (see Note 14).

For the nine months ended September 30, 2022, the Company incurred direct and incremental costs of approximately $31.7 million in connection with the Business Combination and the related equity issuance, consisting primarily of investment banking, legal, accounting, and other professional fees, which were recorded to additional paid-in capital as a reduction of proceeds. An approximate additional $2.6 million of transaction costs were recorded in general and administrative expense related to the liability classified instruments assumed subsequent to the Business Combination in 2022. There were no transaction costs related to the Business Combination recorded in 2023.

Upon closing of the Business Combination, the Company received gross proceeds of $76.1 million from the Business Combination and PIPE Investment, offset by total transaction costs of $40.7 million.

The Company disaggregates its revenue from contracts with customers by country of domicile based on the shipping location of the customer. Total revenue disaggregated by country of domicile is as follows (dollars in thousands):

As of September 30, 2023 and December 31, 2022, the Company had $0.6 million and $0.5 million of deferred revenue included in accrued expenses and other current liabilities, respectively, and no contract assets.

The following tables summarize the Company’s assets and liabilities measured at fair value on a recurring basis, by level, within the fair value hierarchy (in thousands):

Cash equivalents consist primarily of money market funds with original maturities of three months or less at the time of purchase, and the carrying amount is a reasonable estimate of fair value. Short-term investments consist of investment securities with original maturities greater than three months but less than twelve months and are included as current assets in the condensed consolidated balance sheets. For short-term investments, the fair value as of September 30, 2023 and December 31, 2022 approximates amortized cost basis.

Because the transfer of Private Placement Warrants to non-permitted transferees would result in the Private Placement Warrants having substantially the same terms as the Public Warrants, the Company determined that the fair value of each Private Placement Warrant is consistent with that of a Public Warrant. Accordingly, the Private Placement Warrants are classified as Level 2 financial instruments under warrant liability.

The value of the earnout liability is classified as Level 3 under the fair value hierarchy because it has been valued based on significant inputs not observable in the market.

Changes in Level 3 liabilities related to earnout liability measured at fair value for the nine months ended September 30, 2023 were as follows (in thousands):

The gain on change in the fair value of the earnout liability was shown in the condensed consolidated statement of operations and comprehensive income (loss).

Inventories consist of the following as of September 30, 2023 and December 31, 2022 (in thousands):

Inventories are carried and depicted above at the lower of cost or net realizable value. Write-downs were $0.4 million and $0.6 million for the three and nine months ended September 30, 2023, respectively. Write-downs were $0.4 million for each of the three and nine months ended September 30, 2022.

Prepaid expenses and other current assets consisted of the following as of September 30, 2023 and December 31, 2022 (in thousands):

Property and equipment, net, consists of the following as of September 30, 2023 and December 31, 2022 (in thousands):

Depreciation and amortization related to property and equipment was immaterial and $0.4 million for the three and nine months ended September 30, 2023, respectively. Depreciation and amortization related to property and equipment was immaterial and $0.2 million for the three and nine months ended September 30, 2022, respectively.

Accrued expenses and other current liabilities consisted of the following as of September 30, 2023 and December 31, 2022 (in thousands):

On January 4, 2022, Legacy Cepton entered into a loan and security agreement and subsequent amendments (“Trinity Loan Agreement”) with Trinity Capital Inc. (“Trinity”) to borrow up to $25.0 million through January 1, 2023 at a floating per annum rate equal to the greater of (i) 10.75% or (ii) the prime rate plus 7.0%. The loan had a maturity date of February 1, 2026. In connection with the Trinity Loan Agreement, Legacy Cepton issued a warrant to purchase 96,998 shares of Legacy Cepton’s common stock with an exercise price of $16.89 per share (see Note 14). The fair value of the warrant was estimated to be $1.3 million on the date of issuance. On January 4, 2022, Legacy Cepton borrowed $10.0 million under the agreement, incurring $0.3 million in transaction costs which were accounted for as a debt discount. Legacy Cepton also recognized a pro rata portion of the warrant fair value as a debt discount related to the $10.0 million loan. Amortization of debt discounts, in accordance with the effective interest method, are recorded as interest expense in the accompanying condensed consolidated statement of operations and comprehensive income (loss) during 2022. Obligations under the Trinity Loan Agreement were secured by interests in substantially all of the Company’s assets. The agreement contained customary affirmative and negative covenants.

For the three and nine months ended September 30, 2022, the Company recognized $0.4 million and $1.8 million in interest expense, respectively, in connection with the borrowings under the Trinity Loan Agreement.

On November 7, 2022, the Company repaid all outstanding principal and accrued interest under and terminated the Trinity Loan Agreement including a 1.5% prepayment penalty and 2.5% end of term payment.

On October 27, 2022, the Company entered into an Investment Agreement (the “Investment Agreement”) with Koito Manufacturing Co., Ltd. (“Koito”) (See Note 10). Concurrently with the execution of the Investment Agreement, the Company entered into a Secured Term Loan Agreement with Koito to borrow Japanese Yen ¥5.8 billion (approximately $39.4 million) (the “Secured Term Loan Agreement”). The loan accrued interest at a rate equal to 1.0% per annum and was payable at maturity. The Secured Term Loan Agreement entered into with Koito was a related party transaction issued at a below market interest rate. To reflect what a similar debt instrument would be issued at with a market interest rate, the Company recorded a $2.0 million debt discount accounted for as a capital contribution within additional paid-in capital in the condensed consolidated balance sheet as of December 31, 2022. Amortization of the debt discount, in accordance with the effective interest method, was recorded as interest expense in the accompanying condensed consolidated statement of operations and comprehensive income (loss). The loan was set to mature on the earlier of three business days after the closing of the transactions contemplated by the Investment Agreement and the date on which the Investment Agreement is terminated in accordance with its terms. On November 7, 2022, the Company borrowed Japanese Yen ¥5.8 billion (approximately $39.4 million) under the Secured Term Loan Agreement. Obligations under the Secured Term Loan Agreement were secured by interests in substantially all of the Company’s assets, including all patents. The agreement contained customary affirmative and negative covenants. On January 24, 2023, the Company repaid all outstanding principal and accrued interest under the Secured Term Loan Agreement.

For the nine months ended September 30, 2023, the Company recognized $0.3 million in interest expense in connection with the borrowings under the Secured Term Loan Agreement. Additionally, the Company recognized a $0.8 million foreign currency transaction loss on repayment using the applicable exchange rate on January 24, 2023 and a $1.1 million loss on extinguishment of debt.

Prior to the Business Combination, Legacy Cepton had shares of $0.00001 par value Series A, Series B, Series B-1, and Series C preferred stock outstanding, all of which were convertible into shares of common stock of Legacy Cepton on a 1:1 basis, subject to certain anti-dilution protections. Upon the closing of the Business Combination on February 10, 2022, each share of convertible preferred stock issued and outstanding was converted into shares of common stock at the Exchange Ratio. As discussed in Note 2, the Company has retroactively adjusted the shares issued and outstanding prior to February 10, 2022 to give effect to the Exchange Ratio.

On October 27, 2022, the Company entered into the Investment Agreement with Koito pursuant to which, among other things, at the closing of the transactions, and based on the terms and subject to the conditions set forth therein, the Company issued and sold to Koito, 100,000 shares of Series A Convertible Preferred Stock, par value $0.00001 per share (the “Preferred Stock”), for a purchase price of $100.0 million (the “Initial Liquidation Preference”). The issuance and sale of the Preferred Stock and related matters were approved by the Company’s stockholders on January 11, 2023, and the Preferred Stock issued to Koito on January 19, 2023. In connection with the issuance of the Preferred Stock, the Company incurred direct and incremental expenses of $1.1 million, comprised of transaction fees, and financial advisory and legal expenses, which reduced the carrying value of the Preferred Stock.

As of September 30, 2023, the Company had authorized 5,000,000 shares of preferred stock, each with a par value of $0.00001. As of September 30, 2023, there were 100,000 shares of preferred stock issued and outstanding.

The Preferred Stock ranks senior to the Company’s common stock with respect to payment of dividends and rights on the distribution of assets on any liquidation, dissolution or winding up of the affairs of the Company and ranks junior to all secured and unsecured indebtedness. The Preferred Stock has an Initial Liquidation Preference of $100.0 million, representing an aggregate Liquidation Preference (as defined below) of $100.0 million upon issuance. At the Company’s election, the Preferred Stock carries a 4.250% per annum dividend if paid in kind or a 3.250% per annum dividend if paid in cash, in each case payable quarterly in arrears. Holders of the Preferred Stock are entitled to the dividend regardless of whether declared by the Company’s board of directors. Such dividends shall accrue and compound quarterly in arrears from the date of issuance of the shares. The Preferred Stock is also entitled to fully participate in any dividends paid to the holders of common stock in cash, in stock or otherwise, on an as-converted basis.

In the event of any Liquidation, holders of the Preferred Stock are entitled to receive an amount per share equal to the greater of (1) the Initial Liquidation Preference per share plus any accrued or declared but unpaid dividends on such shares (the “Liquidation Preference”) or (2) the amount payable if the Preferred Stock were converted into common stock. The Preferred Stock will have distribution and liquidation rights senior to all other equity interests of the Company. As of September 30, 2023, the Liquidation Preference of the Preferred Stock was $103.0 million.

The Preferred Stock may be converted, at any time in whole or in part at the option of the holder, beginning on January 19, 2024, into shares of the Company’s common stock equal to the quotient obtained by dividing the sum of the Liquidation Preference by the conversion price of $25.85 (the “Conversion Price”), as adjusted to reflect the Reverse Stock Split.

The Conversion Price of the Preferred Stock has customary anti-dilution provisions for stock splits, stock dividends, sales of shares through a tender or exchange offer, including under the Purchase Agreement with Lincoln Park (as defined below), subject to customary exceptions for issuances pursuant to current or future equity-based incentive plans or arrangements (including upon the exercise of employee stock options).

The Company has the option, upon 30 days’ advance notice, to (A) repurchase all (but not less than all) of the outstanding Preferred Stock held by Koito or a Permitted Transferee (as defined in the Investment Agreement) on or after the second anniversary of the closing occurring after the end of the applicable fiscal year for which the Company has recorded positive net income, if the Company has recorded positive net income pursuant to GAAP in its audited financial statements for any fiscal year the end date of which falls after the fifth anniversary of the closing and (B) all or any portion of the outstanding Preferred Stock not held by Koito or a Permitted transferee any time after the seventh anniversary of the closing.

Upon occurrence of a fundamental change event, each holder of outstanding shares of the Preferred Stock has the right to require the Company to repurchase any or all of their Preferred Stock at a purchase price per share equal to the Liquidation Preference or in lieu of a repurchase, elect to convert the Preferred Stock into the Company’s common stock equal to the quotient obtained by dividing 110% of the Liquidation Preference by the Conversion Price.

A fundamental change is defined as either the direct or indirect sale, or other disposition of all or substantially all assets of the Company and its subsidiaries to any third party or the consummation of any transaction, the result of which is that any third party or group of third parties become the beneficial owner of more than 50% of the voting power of the Company. Solely with respect to shares held by Koito, the definition of a fundamental change is expanded to include agreements entered by the Company to issue equity exceeding 10% of the Company’s common stock, or any strategic alliance partnership, or joint venture agreement to a third party deemed to be a competitor with Koito (subject to certain exceptions).

Holders of Legacy Cepton’s common stock were entitled to one vote per share, and to receive dividends when, as and if declared by the board of directors, and, upon liquidation or dissolution, were entitled to receive all assets available for distribution to stockholders. The holders had no preemptive or other subscription rights and there were no redemption or sinking fund provisions with respect to such shares. Upon the closing of the Business Combination on February 10, 2022, each share of Legacy Cepton common stock issued and outstanding was converted into common stock of the Company at the Exchange Ratio.

As of September 30, 2023, the Company had authorized 35,000,000 shares of common stock, each with a par value of $0.00001. As of September 30, 2023, there were 15,846,935 shares of common stock issued and outstanding. See Note 1 Basis of Presentation and Principles of Consolidation for more information regarding the Reverse Stock Split and Authorized Shares Reduction and the retroactive adjustment therefor in this Report.

On November 24, 2021, Legacy Cepton entered into a purchase agreement with Lincoln Park Capital LLC (“Lincoln Park” or “LPC”), pursuant to which Lincoln Park has agreed to purchase up to $100.0 million of common stock (subject to certain limitations contained in the Purchase Agreement) from time to time over a 36-month period (the “Purchase Agreement”) after the consummation of the Business Combination and certain other conditions set forth in the Purchase Agreement. The Company may, from time to time and at its sole discretion, direct Lincoln Park to purchase common stock in accordance with daily dollar thresholds as determined within the Purchase Agreement. The purchase price per share for common stock will be the lower of: (i) the lowest trading price for shares of common stock on the market in which it is listed, on the applicable purchase date and (ii) the average of the three (3) lowest closing sale price for common stock during the ten (10) consecutive business days ending on the business day immediately preceding such purchase date. In consideration for entering into the Purchase Agreement, the Company issued, as a commitment fee, 5,000 shares of common stock to Lincoln Park on the date of the closing of the Business Combination and subsequently an additional 15,000 shares of common stock 180 days after the date of the closing of the Business Combination.

As of September 30, 2023, 114,251 shares of common stock had been sold in aggregate to Lincoln Park under the Purchase Agreement for consideration of $1.7 million. For the three and nine months ended September 30, 2023, no shares of common stock were sold to Lincoln Park under the Purchase Agreement. For the three and nine months ended September 30, 2022, 112,132 and 114,251 shares of common stock, respectively, were sold to Lincoln Park under the Purchase Agreement.

Holders of Legacy Cepton’s Class F stock were entitled to the same voting rights as the equivalent number of common stock on an as-converted basis, and to receive dividends when, as and if declared by the board of directors. The holders had conversion rights for conversion into shares of common stock and preferred stock. The holders were subject to vesting terms wherein each holder acquired a vested interest in the stock over a service period of four years. Upon the closing of the Business Combination on February 10, 2022, each share of Legacy Cepton’s Class F stock issued and outstanding was converted to common stock of the Company at the Exchange Ratio.

On July 5, 2016, Legacy Cepton adopted the 2016 Stock Plan (the “2016 Plan”) under which 4,800,000 shares of Legacy Cepton’s common stock were reserved for issuance to employees, nonemployee directors, consultants, and advisors. As a result of the Business Combination, the Company no longer grants new incentive awards under the 2016 Plan and there were no shares reserved or available for future issuance under the 2016 Plan. Incentive awards existing under the 2016 Plan immediately prior to the Business Combination were converted into options to receive shares of common stock through application of the Exchange Ratio (“Post Conversion Awards”).

On February 10, 2022, the Company adopted the 2022 Stock Plan (the “2022 Plan”) under which 1,512,314 shares of the Company’s common stock, as adjusted to reflect the Reverse Stock Split, were reserved for issuance to employees, nonemployee directors, consultants, and advisors. Per the terms of the 2022 Plan, in the event any Post Conversion Awards issued and outstanding under the 2016 Plan are cancelled, terminated, or expire, said number of shares will be made available for issuance under the 2022 Plan. The share limit shall automatically increase on the first trading day in January of every calendar year during the term of the 2022 Plan, by an amount equal to the lesser of (i) two percent (2%) of the total number of shares of common stock issued and outstanding on December 31 of the immediately preceding calendar year or (ii) such number of shares of common stock as may be established by the board of directors. As of September 30, 2023, as adjusted to reflect the Reverse Stock Split, there were 1,007,264 shares of common stock reserved for issuance under the 2022 Plan.

A summary of the Company’s employee and nonemployee stock option activity for the nine months ended September 30, 2023 is presented below:

During the nine months ended September 30, 2023, the estimated weighted-average grant date fair value of options granted was $2.03 per share. As of September 30, 2023, there was $5.0 million of unrecognized stock-based compensation expense related to unvested stock options expected to be recognized over a weighted-average period of 1.4 years. The total intrinsic value of options exercised during the nine months ended September 30, 2023 was $0.1 million. The Company recognizes forfeitures as they occur.

Each restricted stock unit (“RSU”) granted under the 2022 Plan represents a right to receive one share of the Company’s common stock when the RSU vests. RSUs generally vest over a period of one to four years based on fulfilling a service condition. The fair value of a RSU is equal to the fair value of the Company’s common stock on the date of grant.

A summary of the Company’s RSU activity for the nine months ended September 30, 2023 is presented below:

As of September 30, 2023, there was $9.3 million of unrecognized stock-based compensation expense related to unvested RSUs expected to be recognized over a weighted-average period of 2.3 years. The total intrinsic value of RSUs outstanding at September 30, 2023 was $2.8 million. The Company recognizes forfeitures as they occur.

Each performance-based stock unit (“PSU”) granted under the 2022 Plan represents a right to receive one share of the Company’s common stock upon satisfaction of the performance-based conditions applicable to the PSU. There were no PSUs issued during the nine months ended September 30, 2023. During the nine months ended September 30, 2022, the Company granted 12,300 PSUs under the 2022 Plan, with 6,600 PSUs in the first tranche and 5,700 PSUs in the second tranche. Each grant consisted of two market-based vesting tranches, with the first tranche to vest if, at the close of regular trading for 20 trading days out of any period of 30 consecutive trading days, either (i) the closing price of the Company’s common stock exceeds $150.00 per share or (ii) the Company’s market capitalization exceeds $2.1 billion; and the second tranche to vest if, at the close of regular trading for 20 trading days out of any period of 30 consecutive trading days, either (i) the closing price of the Company’s common stock exceeds $175.00 per share or (ii) the Company’s market capitalization exceeds $2.5 billion, provided in each case that the applicable stock price or market capitalization goal must be achieved no later than February 10, 2025 for the applicable tranche to vest, and provided further that the vesting of each tranche is subject to the grantee’s continued employment with the Company through the day on which the applicable goal is achieved.

The fair value of the PSUs at valuation date was determined using a Monte Carlo valuation model that utilizes significant assumptions, including expected volatility, dividend yield, stock price as of the valuation date, market capitalization targets and the corresponding share price targets necessary for each tranche of PSUs to vest, expected life, and risk-free rate.

The fair value of the PSUs at valuation date was $0.1 million with weighted-average grant date fair value of $9.77, amortizing over a derived service period of 21 and 22 months for each tranche, respectively. As of September 30, 2023, unrecognized stock-based compensation expense related to PSU’s was immaterial, which was expected to be recognized over a weighted-average period of 1.4 years.

For the three and nine months ended September 30, 2023 and 2022, the Company recorded stock-based compensation expense as follows (in thousands):

For the three months ended September 30, 2023 and 2022, the Company capitalized $42 thousand and $42 thousand, respectively, of stock-based compensation expense into inventory. For the nine months ended September 30, 2023 and 2022, the Company capitalized $0.1 million and $0.1 million, respectively, of stock-based compensation expense into inventory. There were no modifications during the three and nine months ended September 30, 2023, or during the three months ended September 30, 2022. During the nine months ended September 30, 2022, the Company recognized additional stock-based compensation expense of $0.3 million as a result of modification of a cancelled option of a nonemployee.

In addition to the shares issued upon closing of the Business Combination (see Note 2), additional contingent shares (“Earnout Shares”) are payable to each holder of common stock and/or options receiving consideration in the Business Combination, in the amounts set forth below (as adjusted to reflect the Reverse Stock Split):

The Company concluded the Earnout Shares meet the criteria for liability classification due to the existence of contingent settlement provisions that could result in holders receiving differing amounts of shares depending on the Company’s stock price or the price paid in a change of control. Because the settlement is not solely determined by the share price of the Company (that is, the share price observed in or implied by a qualifying change-in-control event), but also by the occurrence of a qualifying change-in-control event, this causes the Earnout Shares to not be indexed to the Company’s own shares, resulting in liability classification. Upon the closing of the Business Combination, the Company recorded these instruments as liabilities on the condensed consolidated balance sheet at fair value and will recognize subsequent changes in fair value in earnings at each reporting date.

The fair value of the earnout liability was determined using a Monte Carlo valuation model that utilizes significant assumptions, including expected volatility, expected term, and risk-free rate, to determine the probability of achieving the common share price milestones.

The following table summarizes the assumptions used in estimating the fair value of the earnout liability at each of the relevant periods:

Current stock price: the stock price was based on the closing price as of the valuation date, as adjusted to reflect the Reverse Stock Split.

Expected volatility: the volatility rate was determined using the historical volatility of the Company's stock price and a mix of historical and implied volatilities of selected industry peers deemed to be comparable to the Company’s business, corresponding to the expected term of the awards.

Risk-free interest rate: The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of issuance for zero-coupon U.S. Treasury notes with maturities corresponding to the expected three-year term of the earnout period.

Expected term: The expected term is the remaining term of the three-year earnout period.

Expected dividend yield: The expected dividend rate is zero as the Company currently has no history or expectation of declaring dividends in the foreseeable future.

As of September 30, 2023, the balance of the earnout liability was approximately $0.1 million. For the three and nine months ended September 30, 2023, the Company recorded an immaterial gain and a gain of $0.8 million, respectively, in the condensed consolidated statement of operations and comprehensive income (loss) for the change in fair value of the earnout liability. For the three and nine months ended September 30, 2022, the Company recorded a loss of $1.4 million and a gain of $70.9 million, respectively, in the condensed consolidated statement of operations and comprehensive income (loss) for the change in fair value of the earnout liability.

As part of GCAC’s initial public offering, 8,625,000 Public Warrants were sold. The terms of outstanding warrants and equity-based awards (including exercise price and number of shares issuable thereunder) were proportionately adjusted to reflect the Reverse Stock Split. The as-adjusted terms of the Public Warrants provide that every ten shares of common stock that could have been purchased pursuant to the exercise of warrants prior to the Effective Date represent one share of common stock that may be purchased pursuant to such warrants following the Effective Date. The exercise price for each warrant following the Effective Date equals the product of 10 multiplied by the exercise price prior to the Effective Date; accordingly, the exercise price for the Company’s warrants is $115.00 following the Effective Date. The Public Warrants will expire five years after the completion of the Business Combination, or earlier upon redemption or liquidation. The Public Warrants are listed on Nasdaq under the symbol “CPTNW”.

The Company may redeem the Public Warrants when exercisable, in whole and not in part, at a price of $0.01 per warrant, so long as the Company provides not less than 30 days’ prior written notice of redemption to each warrant holder, and only if the reported last sale of common stock equals or exceeds $180.00 per share for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date the Company sends the notice of redemption to the warrant holders.

Simultaneously with GCAC’s initial public offering, GCAC consummated a private placement of 5,175,000 Private Placement Warrants with the Sponsor. The Private Placement Warrants are identical to the Public Warrants, including with respect to the Reverse Stock Split adjustments described above, except that the Private Placement Warrants and the shares of common stock issuable upon exercise were not transferable, assignable or salable until 30 days after the completion of the Business Combination, subject to certain limited exceptions. Additionally, the Private Placement Warrants are non-redeemable so long as they are held by the initial purchasers or such purchaser’s permitted transferees. If the Private Placement Warrants are held by someone other than the initial stockholders or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants.

The Company concluded the Private Placement Warrants meet the criteria for liability classification due to the existence of a settlement provision that adjusts the settlement amount based on who the holder of the warrant is (i.e., permitted vs. non-permitted transferees). This provision causes the Private Placement Warrants to not be indexed to the Company’s own shares, resulting in liability classification. Upon consummation of the Business Combination, the fair value of the Private Placement Warrants was recorded at a value of approximately $2.6 million. The fair value of the Private Placement Warrants was remeasured on September 30, 2023 at $0.1 million. For the three and nine months ended September 30, 2023, the Company recorded a gain of $0.2 million and $0.3 million, respectively, in the condensed consolidated statement of operations and comprehensive income (loss) for the change in fair value of the liability. For the three and nine months ended September 30, 2022, the Company recorded an immaterial loss and a gain of $1.8 million, respectively, in the condensed consolidated statement of operations and comprehensive income (loss) for the change in fair value of the liability.

In August 2019, Legacy Cepton entered into a loan and security agreement (“2019 Loan Agreement”) with Silicon Valley Bank (“SVB”) that allowed for borrowings of up to $5.0 million under a term loan through July 31, 2020 (which was repaid in February 2020). In connection with the 2019 Loan Agreement, Legacy Cepton issued detachable warrants (“SVB warrants”) to purchase an aggregate of 60,000 shares of Legacy Cepton’s common stock. Immediately prior to the consummation of the Business Combination, the SVB warrants were net exercised and subsequently converted into shares of common stock of the Company.

On January 4, 2022, in connection with the Trinity Loan Agreement, Legacy Cepton issued a warrant (“Trinity warrants”) to purchase 96,998 shares of Legacy Cepton’s common stock with an exercise price of $16.89 per share. The warrant was immediately exercisable and expires on January 4, 2032. The Company concluded the warrant meets the criteria for liability classification due to the existence of contingent settlement provisions that could result in holders receiving differing amounts of shares depending on the Company’s stock price or the price paid in a change of control. Because the settlement is not solely determined by the share price of the Company (that is, the share price observed in or implied by a qualifying change-in-control event), but also by the occurrence of a qualifying change-in-control event, this causes the warrant to not be indexed to the Company’s own shares, resulting in liability classification. The fair value of the warrant was initially estimated to be $1.3 million using the Black-Scholes valuation model. Immediately prior to the consummation of the Business Combination, the Trinity warrants were net exercised and subsequently converted into shares of common stock of the Company. For the nine months ended September 30, 2022, the Company recorded a gain of $0.7 million in the condensed consolidated statement of operations and comprehensive income (loss) for the exercise of the Trinity warrants.

The Company conducts its business globally and its operating income is subject to varying rates of tax in the U.S., Canada, Germany, Hong Kong, China, and the United Kingdom. Consequently, the Company’s effective tax rate is dependent upon the geographic distribution of its earnings or losses and the tax laws and regulations in each geographical region.

The Company’s provision for income taxes was immaterial for each of the three and nine months ended September 30, 2023 and 2022. The Company continues to maintain a full valuation allowance against its U.S. federal and state deferred tax assets.

The Company leases office and manufacturing facilities under non-cancelable operating leases expiring at various dates through April 2028. The Company’s lease agreements do not contain any material terms and conditions of residual value guarantees or material restrictive covenants. The Company adopted ASU 2016-02, Leases (Topic 842) using the modified retrospective method on January 1, 2022.

The Company determines if an arrangement is or contains a lease at inception. Right-of-use assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease right-of-use assets and liabilities are recognized at the commencement date based on an amount equal to the present value of lease payments over the lease term. The Company’s leases do not provide an implicit rate; therefore, the Company uses an incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The Company uses the implicit rate when it is readily determinable. The Company elected the package of practical expedients permitted under the transition guidance within the new standard, which among other things, allowed it to carry forward existing lease classification and to exclude leases with original terms of one year or less. Further, the Company elected to combine lease and non-lease components for all asset classes. Variable lease payments are defined as payments made for the right to use an asset that vary because of changes in facts or circumstances occurring after the commencement date, other than the passage of time. Any variable lease components are expensed as incurred. The operating lease right-of-use assets also include adjustments related to prepaid or deferred lease payments and lease incentives. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. Operating lease expense for lease payments is recognized on a straight-line basis over the lease term.

The components of lease expense for the three and nine months ended September 30, 2023 and 2022 were as follows (in thousands):

Supplemental cash flow information for the nine months ended September 30, 2023 and 2022 related to leases was as follows (in thousands):

Supplemental balance sheet information related to leases was as follows (in thousands):

The non-current portion of the operating lease right-of-use assets was recorded in other assets in the condensed consolidated balance sheets.

Weighted-average remaining term and discount rates were as follows (term in years):

Maturities of lease liabilities were as follows (in thousands):

From time to time, the Company may be involved in various legal claims, litigation and other matters that arise in the normal course of its operations. Although there can be no assurances and the outcome of these matters is currently not determinable, the Company currently believes that none of these claims, actions or proceedings are likely to have a material adverse effect on the Company’s financial position.

The Company records accruals for our outstanding legal proceedings, investigations or claims when it is probable that a liability will be incurred, and the amount of loss can be reasonably estimated. The Company evaluated developments in legal proceedings, investigations or claims that could affect the amount of any accrual, as well as any developments that would result in a loss contingency to become both probable and reasonably estimable. There were no material accruals for loss contingencies associated with such legal claims, actions or litigation as of September 30, 2023.

On October 27, 2022, the Company entered into the Investment Agreement with Koito pursuant to which, among other things, at the closing of the transactions, and based on the terms and subject to the conditions set forth therein, the Company issued and sold to Koito 100,000 shares of Preferred Stock for a purchase price of $100.0 million. The issuance and sale of the Preferred Stock and related matters were approved by the Company’s stockholders on January 11, 2023, and the Preferred Stock issued to Koito on January 19, 2023. See Note 10 to the condensed consolidated financial statements for further information. At the closing of the issuance of the Preferred Stock, the Company and Koito entered into the Investor Rights Agreement (the “Investor Rights Agreement”), pursuant to which, among other things, the Company ensured that two designees of Koito sat on the Company’s board of directors immediately following the issuance of the Preferred Stock. The Investor Rights Agreement also provides for certain investor consent, preemptive, registration, and termination rights, which contain certain provisions that limit the Company’s ability to access additional sources of funding without Koito’s consent.

Concurrently with the execution of the Investment Agreement, the Company entered into a Secured Term Loan Agreement with Koito to borrow Japanese Yen ¥5.8 billion (approximately $39.4 million). On January 24, 2023, the Company repaid all outstanding principal and accrued interest under the Secured Term Loan Agreement. See Note 9 to the condensed consolidated financial statements for further information.

Koito is an automotive tier 1 partner and investor of the Company. Sales to Koito were $2.1 million and $0.3 million for the three months ended September 30, 2023 and 2022, respectively. Sales to Koito were $4.2 million and $2.1 million for the nine months ended September 30, 2023 and 2022, respectively. Accounts receivable from Koito were $0.8 million as of September 30, 2023 and $1.0 million as of December 31, 2022.

The Company follows the two-class method when computing net income (loss) per common share when shares are issued that meet the definition of participating securities. The Company was in a net loss position for the three and nine months ended September 30, 2023 and for the three months ended September 30, 2022. The Company was in a net income position for the nine months ended September 30, 2022. The Company considers its Preferred Stock outstanding as of September 30, 2023 to be participating as holders of such securities have non-forfeitable dividend rights in the event of the declaration of a dividend for shares of common stock. When the Company is in a net loss position, the net loss attributable to common stockholders is not allocated to the Preferred Stock under the two-class method as these securities do not have a contractual obligation to share in losses. Basic net income (loss) per share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of shares of the Company’s common stock outstanding. When there is a net loss attributable to common stockholders, potentially dilutive common stock equivalents have been excluded from the calculation of diluted net loss per share attributable to common stockholders as their effect is anti-dilutive.

The following table present reconciliations of the denominators of basic and diluted net (loss) income per share:

The following common stock equivalents were excluded from the computation of diluted net (loss) income per share for the periods presented because including them would have been antidilutive: